Annual ROE
-74.61%
-21.41%-40.24%
31 December 2023
Summary:
Tonix Pharmaceuticals Holding annual return on equity is currently -74.61%, with the most recent change of -21.41% (-40.24%) on 31 December 2023. During the last 3 years, it has fallen by -17.04% (-29.60%). TNXP annual ROE is now -106.67% below its all-time high of 1119.37%, reached on 31 December 2010.TNXP ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROE
-150.01%
-5.92%-4.11%
30 September 2024
Summary:
Tonix Pharmaceuticals Holding quarterly return on equity is currently -150.01%, with the most recent change of -5.92% (-4.11%) on 30 September 2024. Over the past year, it has dropped by -73.65% (-96.45%). TNXP quarterly ROE is now -102.86% below its all-time high of 5241.04%, reached on 30 September 2011.TNXP Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TNXP ROE Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -40.2% | -96.5% |
| 3 y3 years | -29.6% | -204.3% |
| 5 y5 years | +32.3% | +12.5% |
TNXP ROE High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -76.8% | at low | -241.3% | at low |
| 5 y | 5 years | -76.8% | +75.5% | -241.3% | +34.6% |
| alltime | all time | -106.7% | +92.4% | -102.9% | +98.6% |
Tonix Pharmaceuticals Holding ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -150.01%(+4.1%) |
| June 2024 | - | -144.09%(+73.5%) |
| Mar 2024 | - | -83.03%(-5.3%) |
| Dec 2023 | -74.61%(+40.2%) | -87.67%(+14.8%) |
| Sept 2023 | - | -76.36%(+16.1%) |
| June 2023 | - | -65.78%(+21.3%) |
| Mar 2023 | - | -54.25%(+11.2%) |
| Dec 2022 | -53.20%(+26.1%) | -48.78%(+3.3%) |
| Sept 2022 | - | -47.23%(+7.5%) |
| June 2022 | - | -43.95%(-9.3%) |
| Mar 2022 | - | -48.46%(+2.2%) |
| Dec 2021 | -42.19%(-26.7%) | -47.43%(-3.8%) |
| Sept 2021 | - | -49.29%(-14.6%) |
| June 2021 | - | -57.69%(-14.0%) |
| Mar 2021 | - | -67.08%(-21.9%) |
| Dec 2020 | -57.57%(-81.1%) | -85.88%(-20.1%) |
| Sept 2020 | - | -107.52%(-26.4%) |
| June 2020 | - | -146.01%(-22.0%) |
| Mar 2020 | - | -187.29%(-18.3%) |
| Dec 2019 | -303.90%(+175.6%) | -229.38%(+33.8%) |
| Sept 2019 | - | -171.46%(+16.0%) |
| June 2019 | - | -147.87%(+3.4%) |
| Mar 2019 | - | -142.97%(-1.6%) |
| Dec 2018 | -110.25%(+28.5%) | -145.29%(+10.2%) |
| Sept 2018 | - | -131.88%(+19.0%) |
| June 2018 | - | -110.78%(+27.5%) |
| Mar 2018 | - | -86.87%(+12.3%) |
| Dec 2017 | -85.81%(-44.0%) | -77.35%(-8.0%) |
| Sept 2017 | - | -84.06%(-8.5%) |
| June 2017 | - | -91.89%(-19.8%) |
| Mar 2017 | - | -114.59%(-19.0%) |
| Dec 2016 | -153.16% | -141.45%(-1.4%) |
| Sept 2016 | - | -143.40%(+6.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2016 | - | -134.12%(+6.6%) |
| Mar 2016 | - | -125.77%(+28.3%) |
| Dec 2015 | -119.35%(+56.0%) | -98.05%(+7.7%) |
| Sept 2015 | - | -91.07%(+10.1%) |
| June 2015 | - | -82.74%(+15.5%) |
| Mar 2015 | - | -71.64%(+10.6%) |
| Dec 2014 | -76.52%(-54.2%) | -64.80%(+2.2%) |
| Sept 2014 | - | -63.41%(-9.7%) |
| June 2014 | - | -70.24%(-27.6%) |
| Mar 2014 | - | -97.03%(-79.2%) |
| Dec 2013 | -167.14%(-83.0%) | -465.88%(-55.0%) |
| Sept 2013 | - | -1034.47%(-171.0%) |
| June 2013 | - | 1457.55%(-113.9%) |
| Mar 2013 | - | -10.49 K%(+72.2%) |
| Dec 2012 | -985.40%(-796.8%) | -6089.90%(-605.7%) |
| Sept 2012 | - | 1204.34%(-16.5%) |
| June 2012 | - | 1442.06%(+107.4%) |
| Mar 2012 | - | 695.19%(+77.4%) |
| Dec 2011 | 141.41%(-87.4%) | 391.98%(-92.5%) |
| Sept 2011 | - | 5241.04%(+45.2%) |
| June 2011 | - | 3609.43%(+14.2%) |
| Mar 2011 | - | 3161.93%(-33.4%) |
| Dec 2010 | 1119.37%(-534.7%) | 4750.91%(-1804.5%) |
| Sept 2010 | - | -278.73%(+82.7%) |
| June 2010 | - | -152.53%(-23.4%) |
| Mar 2010 | - | -199.23%(+25.1%) |
| Dec 2009 | -257.50%(+423.6%) | -159.28%(+41.7%) |
| Sept 2009 | - | -112.44%(-20.7%) |
| June 2009 | - | -141.86%(+9.0%) |
| Mar 2009 | - | -130.13%(-32.6%) |
| Dec 2008 | -49.18% | -193.14%(-97.1%) |
| Sept 2008 | - | -6750.00%(+1009.3%) |
| June 2008 | - | -608.51%(+238.1%) |
| Mar 2008 | - | -180.00% |
FAQ
- What is Tonix Pharmaceuticals Holding annual return on equity?
- What is the all time high annual ROE for Tonix Pharmaceuticals Holding?
- What is Tonix Pharmaceuticals Holding annual ROE year-on-year change?
- What is Tonix Pharmaceuticals Holding quarterly return on equity?
- What is the all time high quarterly ROE for Tonix Pharmaceuticals Holding?
- What is Tonix Pharmaceuticals Holding quarterly ROE year-on-year change?
What is Tonix Pharmaceuticals Holding annual return on equity?
The current annual ROE of TNXP is -74.61%
What is the all time high annual ROE for Tonix Pharmaceuticals Holding?
Tonix Pharmaceuticals Holding all-time high annual return on equity is 1119.37%
What is Tonix Pharmaceuticals Holding annual ROE year-on-year change?
Over the past year, TNXP annual return on equity has changed by -21.41% (-40.24%)
What is Tonix Pharmaceuticals Holding quarterly return on equity?
The current quarterly ROE of TNXP is -150.01%
What is the all time high quarterly ROE for Tonix Pharmaceuticals Holding?
Tonix Pharmaceuticals Holding all-time high quarterly return on equity is 5241.04%
What is Tonix Pharmaceuticals Holding quarterly ROE year-on-year change?
Over the past year, TNXP quarterly return on equity has changed by -73.65% (-96.45%)